相关实验视频

Updated: Sep 17, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

一个基于计算的新治疗策略,使用三臂RCT对儿童的Mycoplasma pneumoniae肺炎进行治疗

Chengliang Zhong¹, Qingyuan Liu², Shengxuan Guo¹

¹National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.

Chinese medicine

|July 2, 2025

概括

金口服液与阿兹胺结合,显著缩短了儿童中Mycoplasma pneumoniae肺炎的康复时间. 这种组合疗法可以改善预后和缓解症状,证明了良好的安全性和临床价值.

科学领域:

儿童传染病儿童传染病
药理学和治疗学药理学和治疗学
计算生物学和网络医学.

背景情况:

菌性肺炎肺炎 (MPP) 在学龄儿童和青少年中很普遍.
金津口服液 (JZOL) 和亚胺素 (AZ) 是已知的治疗方法,但它们对MPP的联合机制和疗效尚未完全理解.
了解TCM和西方医学结合的协同效应对于优化儿科呼吸道感染治疗至关重要.

研究的目的:

通过计算分析阐明用于MPP的JZOL和AZ联合治疗的模块化网络调节机制.
通过一项随机临床试验,评估不同剂量JZOL与AZ联合用于治疗儿科MPP的协同治疗效果和安全性.

主要方法:

网络目标分析被用来识别模块化机制,重点关注像TNF信号传递这样的途径.
进行了一项随机,双盲,三臂,并行控制,多中心临床研究.
评估了临床结果,包括恢复时间,发烧缓解,咳/缓解,胸部X射线改善和TCM症状愈合.

主要成果:

与安慰剂 (8天) 相比,组合疗法在临床恢复的中位时间 (双剂量5天,常规剂量6天) 中显示了统计学上显著的减少.
在治疗组之间观察到发烧缓解,咳/的缓解,胸部X射线愈合和TCM症状缓解的时间有显著改善.
不同剂量的JZOL与AZ相结合,有效地缩短了疾病持续时间,缓解了症状,并改善了患者预后,并具有良好的安全性.

结论:

JZOL和AZ的联合治疗在治疗儿科MPP方面表现出协同效应,提供更快的恢复和症状缓解.
该研究验证了一种研究方法,将计算预测与临床试验相结合,以加速药物开发.
这种联合治疗策略显示出由于其在治疗儿科MPP中的有效性和安全性,有望获得临床推广.

关键词:

菌性肺炎 (Mycoplasma pneumoniae) 是一种肺炎.亚齐思罗密辛是一种亚齐思罗密辛.共同农业政策,社区感染性肺炎锦口服液体的使用情况网络目标网络目标网络目标临床试验 RCT 临床试验

更多相关视频

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

相关概念视频

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....